Sort
51,570 grants matching “autoimmune disease”
Integrative genomic analysis of the human response to glucocorticoids
$432,807Luis M Franco · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Tissue-engineered lymph node stroma to study peripheral tolerance in autoimmune diabetes
$432,804Alice Tomei · University Of Miami School Of Medicine · R56 · FY2021 · AI
Host Immunity Against Bacteria
$432,768Sandip Datta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Humoral Immune Mechanisms of Acute and Chronic Neurologic Sequelae of COVID-19
$432,694Michael R Wilson · University Of California, San Francisco · R01 · FY2025 · NS
Genetically altered mice to study ocular function and pathology
$432,692Eric Wawrousek · National Eye Institute · Z01 · FY2007 · EY
Lipid Homeostasis, Immunity and Atherosclerosis
$432,684Catherine C Hedrick · La Jolla Institute For Immunology · R01 · FY2013 · HL
Defining the developmental and toxicological roles of the AHR-regulated Sox9 lncRNA in zebrafish
$432,680Robert L Tanguay · Oregon State University · R01 · FY2021 · ES
Molecular Aspects of Leukocyte Antimicrobial Peptides
$432,609Michael E Selsted · University Of Southern California · R01 · FY2014 · AI
Resource for Nonhuman Primate Immune Reagents
$432,561Francois J Villinger · University Of Louisiana At Lafayette · R24 · FY2024 · OD
Molecular Probes of the Mechanisms of Cytocrhome P450
$432,556John T Groves · Princeton University · R37 · FY2009 · GM
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2023 · AI
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2024 · AI
Project 3 - Modulation of Antiviral Immunity and T cell Exhaustion by Inhibitory Receptors
$432,549E. John Wherry · University Of Pittsburgh At Pittsburgh · P01 · FY2021 · AI
Expanded Double Negative T cells in SLE
$432,500George C Tsokos · Beth Israel Deaconess Medical Center · R01 · FY2016 · AI
Activation of eNOS by Steroid Hormones
$432,500Brigham And Women'S Hospital · R01 · FY2005 · HL
Personal tumor neoantigens for immunity against chronic lymphocytic leukemia
$432,500Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · R01 · FY2015 · CA
Expanded Double Negative T cells in SLE
$432,500George C Tsokos · Beth Israel Deaconess Medical Center · R01 · FY2019 · AI
Expanded Double Negative T cells in SLE
$432,500George C Tsokos · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI
Activation of eNOS by Steroid Hormones
$432,500Brigham And Women'S Hospital · R01 · FY2004 · HL
Activation of eNOS by Steroid Hormones
$432,500Brigham And Women'S Hospital · R01 · FY2003 · HL
Expanded Double Negative T cells in SLE
$432,500George C Tsokos · Beth Israel Deaconess Medical Center · R01 · FY2017 · AI
Molecular study mouse virus resistance mechanisms
$432,438Michael G Brown · University Of Virginia · R01 · FY2017 · AI
Mechanophenotyping RBC subpopulations in ME/CFS
$432,431Anand K Ramasubramanian · San Jose State University · R15 · FY2025 · HL
Long noncoding RNAs and their contribution to 22q11.2 deletion syndrome
$432,410Nicolai Stanislas Cyrille Van Oers · Ut Southwestern Medical Center · R01 · FY2017 · AI
Long noncoding RNAs and their contribution to 22q11.2 deletion syndrome
$432,410Nicolai Stanislas Cyrille Van Oers · Ut Southwestern Medical Center · R01 · FY2019 · AI